Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 2
1992 1
1994 1
1998 2
1999 1
2001 2
2002 1
2004 1
2005 3
2007 2
2008 1
2009 2
2010 6
2011 2
2012 2
2013 7
2014 3
2016 1
2017 2
2018 1
2021 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Vedolizumab as induction and maintenance therapy for Crohn's disease.
Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S, Bressler B, Fox I, Rosario M, Sankoh S, Xu J, Stephens K, Milch C, Parikh A; GEMINI 2 Study Group. Sandborn WJ, et al. N Engl J Med. 2013 Aug 22;369(8):711-21. doi: 10.1056/NEJMoa1215739. N Engl J Med. 2013. PMID: 23964933 Free article. Clinical Trial.
Mesalazine-induced renal calculi.
Jacobsson H, Eriksen J, Karlén P. Jacobsson H, et al. Among authors: karlen p. Am J Case Rep. 2013 Dec 23;14:551-3. doi: 10.12659/AJCR.889719. eCollection 2013. Am J Case Rep. 2013. PMID: 24478817 Free PMC article.
Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study.
Visuri I, Eriksson C, Karlqvist S, Lykiardopoulos B, Karlén P, Grip O, Söderman C, Almer S, Hertervig E, Marsal J, Malmgren C, Delin J, Strid H, Sjöberg M, Bergemalm D, Hjortswang H, Halfvarson J. Visuri I, et al. Among authors: karlen p. Therap Adv Gastroenterol. 2023 May 30;16:17562848231174953. doi: 10.1177/17562848231174953. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37274297 Free PMC article.
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.
Danese S, Colombel JF, Lukas M, Gisbert JP, D'Haens G, Hayee B, Panaccione R, Kim HS, Reinisch W, Tyrrell H, Oh YS, Tole S, Chai A, Chamberlain-James K, Tang MT, Schreiber S; GARDENIA Study Group. Danese S, et al. Lancet Gastroenterol Hepatol. 2022 Feb;7(2):118-127. doi: 10.1016/S2468-1253(21)00294-6. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798038 Free article. Clinical Trial.
[Colitis cancer--myth or reality?].
Hertervig E, Befrits R, Ekbom A, Karlén P, Lindberg J, Löfberg R, Rutegård J, Sjöqvist U, Ost A. Hertervig E, et al. Among authors: karlen p. Lakartidningen. 2009 Nov 4-12;106(45):3000-2. Lakartidningen. 2009. PMID: 19998826 Review. Swedish. No abstract available.
Naïve T cells in the gut: how to really find them?
Karlsson M, Linton L, Lampinen M, Karlén P, Glise H, Befrits R, Janczewska I, Carlson M, Winqvist O, Eberhardson M. Karlsson M, et al. Among authors: karlen p. Scand J Gastroenterol. 2014 Apr;49(4):518. doi: 10.3109/00365521.2014.884159. Epub 2014 Feb 3. Scand J Gastroenterol. 2014. PMID: 24484322 No abstract available.
Evidence for immunosurveillance in intestinal premalignant lesions.
Karlsson M, Lindberg K, Karlén P, Ost A, Thörn M, Winqvist O, Eberhardson M. Karlsson M, et al. Among authors: karlen p. Scand J Immunol. 2010 May;71(5):362-8. doi: 10.1111/j.1365-3083.2010.02377.x. Scand J Immunol. 2010. PMID: 20500687 Free article.
Crohn's disease and cancer: a population-based cohort study.
Persson PG, Karlén P, Bernell O, Leijonmarck CE, Broström O, Ahlbom A, Hellers G. Persson PG, et al. Among authors: karlen p. Gastroenterology. 1994 Dec;107(6):1675-9. doi: 10.1016/0016-5085(94)90807-9. Gastroenterology. 1994. PMID: 7958678
45 results